ALKBH5-mediated m(6)A demethylation of FOXM1 mRNA promotes progression of uveal melanoma

In this study, we found that ALKBH5, a key component of the N(6)-methyladenosine (m(6)A) methyltransferase complex, was significantly elevated in uveal melanoma (UM) cell lines and that ALKBH5 downregulation inhibited tumor growth in vivo. High ALKBH5 expression predicted worse outcome in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Lili, Yin, Jiayang, Yang, Hong, Li, Chaoxuan, Zhu, Linxin, Liu, Lian, Zhong, Jingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906204/
https://www.ncbi.nlm.nih.gov/pubmed/33428593
http://dx.doi.org/10.18632/aging.202371
Descripción
Sumario:In this study, we found that ALKBH5, a key component of the N(6)-methyladenosine (m(6)A) methyltransferase complex, was significantly elevated in uveal melanoma (UM) cell lines and that ALKBH5 downregulation inhibited tumor growth in vivo. High ALKBH5 expression predicted worse outcome in patients with UM. EP300-induced H3K27 acetylation activation increased ALKBH5 expression. Downregulation of ALKBH5 inhibited UM cell proliferation, migration, and invasion and increased apoptosis in vitro. Besides, ALKBH5 may promote UM metastasis by inducing epithelial-to-mesenchymal transition (EMT) via demethylation of FOXM1 mRNA, which increases its expression and stability. In sum, our study indicates that AKLBH5-induced m(6)A demethylation of FOXM1 mRNA promotes UM progression. Therefore, AKLBH5 is a potential prognostic biomarker and therapeutic target in UM.

Ejemplares similares